Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Contact

Faster, Cleaner, Better.

quotes
- Price Overview
- Performance Report
charts
- Interactive Chart
- Snapshot Chart
technicals
company
analysts
- Earnings Estimates
- Analyst Ratings
financials

Quantum Genomics (QNNTF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

News & Headlines for [[ item.sessionDateDisplayLong ]]

Help

Quantum Genomics announces the appointment of its new Scientific Advisory Board Globe Newswire - Mon Jun 27, 2022

PARIS, June 27, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specializing in the...

Quantum Genomics announces the appointment of its new Scientific Advisory Board Globe Newswire - Mon Jun 27, 2022

PARIS, June 27, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specializing in the...

Quantum Genomics Announces the End of Patient Recruitment for its Phase III Pivotal Study FRESH Globe Newswire - Mon May 9, 2022

PARIS, May 09, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specializing in the...

Quantum Genomics Appoints Sarah Merlen Boulenger as Head of Regulatory Affairs Globe Newswire - Wed May 4, 2022

PARIS, May 04, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth : ALQGC, OTCQX : QNNTF), a biopharmaceutical company specializing in the...

Quantum Genomics Publishes its Results for Fiscal Year 2021 and Provides a Corporate Update Globe Newswire - Thu Apr 28, 2022

PARIS, April 28, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specialising in the...

Quantum Genomics Announces Successful Capital Raise with a Gross Sum of Approximately 15.6M€ Globe Newswire - Wed Apr 27, 2022

Quantum Genomics has equipped itself with new financial means to pursue the development of firibastat and explore new therapeutic fields based on the...

Quantum Genomics Raises a Gross Amount of Approximately € 15 M Globe Newswire - Tue Apr 26, 2022

Launch of capital increase of approximately €15 million for institutional investors with cancellation of the pre-emptive subscription rightA minimum of €12...

Quantum Genomics Announces Publication of a New Scientific Article Featuring QGC606 Globe Newswire - Thu Mar 31, 2022

PARIS, March 31, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth : ALQGC, OTCQX : QNNTF), a biopharmaceutical company specializing in the...

Quantum Genomics Announces Granting of New Patents Protecting QGC606 Globe Newswire - Mon Mar 28, 2022

PARIS, March 28, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth : ALQGC, OTCQX : QNNTF), a biopharmaceutical company specializing in the...

MAIN MENU

POPULAR

quotes

charts

technicals

company

analysts

financials

Quantum Genomics (QNNTF)

Barchart Exclusives

Want to use this as
your default charts setting?

Switch the Market flag

Want Streaming Chart Updates?

Need More Chart Options?

MAIN MENU

POPULAR

quotes

charts

technicals

company

analysts

financials

Quantum Genomics (QNNTF)

Barchart Exclusives

Want to use this as your default charts setting?

Switch the Market flag

Want Streaming Chart Updates?

Need More Chart Options?

Want to use this as
your default charts setting?